Chinanews.com, August 15th. There are more than 21.23 million confirmed cases of new coronary pneumonia worldwide. The research and development of the new crown vaccine, which is considered to be the "antidote" to the world, is continuing to advance.
US President Trump said on the 14th that the country’s vaccine will be “come out soon”; Indian Prime Minister Modi said on the same day that the government will mass-produce potential vaccines and provide vaccines to every citizen. At the same time, Russia’s first registered new crown vaccine has been questioned by some European and American countries because of its safety and effectiveness. Russia said it would publish clinical research data.
On May 21, local time, US President Trump inspected the factory in Ford, Michigan, and was photographed by the media as not wearing a mask.
Trump says vaccine "comes soon"
Fauci worried that Americans refused to vaccinate
On August 14, local time, when Trump was asked about Russia's first registered vaccine, he said that he hoped this vaccine would work. But at the same time, the United States may soon prepare its own vaccine.
Trump said that a vaccine in the United States may be approved and distributed before the end of 2020. "There are currently three candidate vaccines entering Phase III clinical trials and are progressing as planned." He pointed out that more than 100 million doses of vaccine will be prepared by the end of 2020, and 500 million doses of vaccine will be prepared soon.
However, according to a poll jointly released by National Public Radio (NPR) and Public Television Network (PBS) on August 14th, after the successful development of the new crown vaccine, 35% of Americans will choose not to vaccinate, and 60% of people will choose not to vaccinate. Hope to be vaccinated, and 5% of people are still uncertain.
Polls show that people with a college degree are 19% higher than those without a college degree, and Democrats are 23% higher than Republicans.
Fauci, director of the National Institute of Allergy and Infectious Diseases, previously stated that he is worried that people in some parts of the United States may have unnecessary doubts about the new crown vaccine, which may prolong the spread of the virus.
On July 21, local time, in Mumbai, India, a non-governmental organization health volunteer wearing protective clothing and a smart helmet equipped with a thermal scanning sensor was checking the body temperature of residents in residential areas.
Multi-country advances vaccine research and development
UK and EU vaccine "pre-orders" are in progress
In a speech celebrating India’s Independence Day on the 14th, Indian Prime Minister Narendra Modi also stated that the new crown vaccine made in India will “be on the market soon.”
Modi said, “We are all waiting for the new coronary pneumonia vaccine. What I want to tell you is that China’s three candidate vaccines are in different stages of testing.” He said that the government will produce these potential vaccines on a large scale to provide People provide vaccines.
In addition, Israel, South Africa and Kazakhstan have successively announced that they will start clinical trials. At present, there are about 165 vaccines in the world in the trial stage, 26 are in the clinical trial stage, and six are in the phase III clinical trial stage.
The "rush to buy" vaccines is also in full swing. The British government announced on the 14th that the country once again signed an order to purchase 90 million doses of the new crown vaccine. Up to now, the UK has ordered 6 preparatory vaccines currently in clinical trials, with a total of 340 million doses.
The European Commission announced on the same day that it reached a purchase agreement with AstraZeneca Pharmaceuticals on the same day. Once the company's new crown vaccine is proven to be safe and effective, it will purchase 300 million doses of the new crown vaccine from the company and have the right to purchase an additional 100 million doses.
Recently, at the "Gamalea" National Research Center for Epidemiology and Microbiology in Moscow, Russia, staff demonstrated the new crown vaccine.
Russia's vaccine is controversial
Will publish clinical research data
Recently, Russia announced the registration of the world’s first new crown vaccine "Satellite V". Russian President Vladimir Putin said that the vaccine has passed the necessary tests and can fully and effectively function and stably produce antibodies. However, this rapidly developed vaccine has raised doubts about its safety and effectiveness in some European and American countries.
Generally speaking, a vaccine needs to pass the test of three or three phases of clinical trials from clinical trials to market launches. Some European and American experts pointed out that the Russian vaccine has not yet been registered in Phase III clinical trials, and its safety and effectiveness need further verification.
Michael Hyde, a senior researcher in global health at the University of Southampton in the United Kingdom, said, "There is currently no relevant research data on Russian vaccines for the global health community to review."
August 11, local time, Moscow, Russia, Binnopharm's new crown vaccine production laboratory. Image source: People's Vision
In this regard, Russian Health Minister Murashko said that in the next few days, preclinical and clinical research data on the Russian new coronavirus vaccine will be released in response to doubts from European and American countries. He also said, "According to the results, the vaccine has shown high efficiency and safety."
Gunzburg, director of the National Research Center for Epidemiology and Microbiology, the Russian research and development unit "Gamaleya", said that foreign negative comments on Russian vaccines are related to competition. According to the plan, the center will start a 5-month phase 3 clinical trial in August, involving approximately 2,000 adults.
At present, Kazakhstan, Vietnam, Serbia and other countries have all expressed interest in Russian vaccines, and more than 20 countries have applied for orders.